Suppr超能文献

相似文献

1
2
Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity.
Am J Physiol Regul Integr Comp Physiol. 2019 Nov 1;317(5):R733-R745. doi: 10.1152/ajpregu.00153.2019. Epub 2019 Sep 4.
3
PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis.
J Nutr Biochem. 2017 Jan;39:77-85. doi: 10.1016/j.jnutbio.2016.09.015. Epub 2016 Oct 11.
4
Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice.
Nutr Res. 2013 Jul;33(7):586-93. doi: 10.1016/j.nutres.2013.05.004. Epub 2013 Jun 10.
10
Dietary isoflavone supplementation modulates lipid metabolism via PPARalpha-dependent and -independent mechanisms.
Physiol Genomics. 2006 Jun 16;26(1):8-14. doi: 10.1152/physiolgenomics.00155.2005. Epub 2006 Feb 28.

引用本文的文献

1
PPARα activator irbesartan suppresses the proliferation of endometrial carcinoma cells via SREBP1 and ARID1A.
Oncol Res. 2023 May 24;31(3):239-253. doi: 10.32604/or.2023.026067. eCollection 2023.
2
Relationship of Sulfatides Physiological Function and Peroxisome Proliferator-Activated Receptor α.
Neurochem Res. 2023 Jul;48(7):2059-2065. doi: 10.1007/s11064-023-03895-y. Epub 2023 Mar 6.
3
Review article: vascular effects of PPARs in the context of NASH.
Aliment Pharmacol Ther. 2022 Jul;56(2):209-223. doi: 10.1111/apt.17046. Epub 2022 Jun 5.
4
Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs.
Food Chem Toxicol. 2022 Jun;164:113008. doi: 10.1016/j.fct.2022.113008. Epub 2022 Apr 15.
6
Madecassoside Inhibits Body Weight Gain Modulating SIRT1-AMPK Signaling Pathway and Activating Genes Related to Thermogenesis.
Front Endocrinol (Lausanne). 2021 Mar 9;12:627950. doi: 10.3389/fendo.2021.627950. eCollection 2021.
7
Coagulopathy in Malnourished Mice Is Sexually Dimorphic and Regulated by Nutrient-Sensing Nuclear Receptors.
Hepatol Commun. 2020 Oct 22;4(12):1835-1850. doi: 10.1002/hep4.1622. eCollection 2020 Dec.
8
Integrative Analysis Reveals Subtype-Specific Regulatory Determinants in Triple Negative Breast Cancer.
Cancers (Basel). 2019 Apr 10;11(4):507. doi: 10.3390/cancers11040507.

本文引用的文献

1
Targeting nuclear receptors for the treatment of fatty liver disease.
Pharmacol Ther. 2017 Nov;179:142-157. doi: 10.1016/j.pharmthera.2017.05.011. Epub 2017 May 23.
2
Angiotensin-converting enzyme inhibitors attenuate propofol-induced pro-oxidative and antifibrinolytic effect in human endothelial cells.
J Renin Angiotensin Aldosterone Syst. 2017 Jan;18(1):1470320316687197. doi: 10.1177/1470320316687197.
3
PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis.
J Nutr Biochem. 2017 Jan;39:77-85. doi: 10.1016/j.jnutbio.2016.09.015. Epub 2016 Oct 11.
4
Peroxisome proliferator-activated receptor α-dependent renoprotection of murine kidney by irbesartan.
Clin Sci (Lond). 2016 Nov 1;130(21):1969-1981. doi: 10.1042/CS20160343. Epub 2016 Aug 5.
6
Serum sulfatide abnormality is associated with increased oxidative stress in hemodialysis patients.
Hemodial Int. 2015 Jul;19(3):429-38. doi: 10.1111/hdi.12270. Epub 2015 Feb 3.
7
Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
Biochim Biophys Acta. 2015 Mar;1852(3):473-81. doi: 10.1016/j.bbadis.2014.12.011. Epub 2014 Dec 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验